Drawing for GENOMISENSE

USPTO serial 87672522

GENOMISENSE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
SAKAI, ADA HAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GENOMISENSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
044Providing medical information to individuals and families not formally schooled in biological and/or medical sciences in the form of reports in the field of Genomics and Individualized Medicine; Providing medical information, consultancy and advisory services; Providing personalized healthcare and medical information in the nature of Genomics and Individualized Medicine; Providing a web site featuring educational information regarding nutrition and genetics; Web-based health assessment services, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information; Providing educational information about healthcareACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 21, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 21, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 31, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 30, 2020EX5GSOU EXTENSION 5 GRANTED
Oct 26, 2020EXT5SOU EXTENSION 5 FILED
Oct 26, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 18, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 16, 2020EX4GSOU EXTENSION 4 GRANTED
Apr 16, 2020EXT4SOU EXTENSION 4 FILED
Apr 16, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2019EX3GSOU EXTENSION 3 GRANTED
Nov 4, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 31, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 31, 2019EXT3SOU EXTENSION 3 FILED
Oct 31, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 4, 2019EX2GSOU EXTENSION 2 GRANTED
May 4, 2019EXT2SOU EXTENSION 2 FILED
May 4, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 15, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 13, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 13, 2018EX1GSOU EXTENSION 1 GRANTED
Nov 13, 2018EXT1SOU EXTENSION 1 FILED
Nov 13, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 20, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 20, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 15, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 15, 2018XAECEXAMINER'S AMENDMENT ENTERED
Feb 15, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 15, 2018GNEAEXAMINERS AMENDMENT E-MAILED
Feb 15, 2018CNEAEXAMINERS AMENDMENT -WRITTEN
Feb 15, 2018DOCKASSIGNED TO EXAMINER
Dec 8, 2017AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Dec 5, 2017ALIEASSIGNED TO LIE
Nov 27, 2017PARITEAS VOLUNTARY AMENDMENT RECEIVED
Nov 15, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance